This is a demo store. No orders will be fulfilled.
Industries
Subscribe to RSS Feed-
29 Dec 2014  |  Global  |  Technology Research
Emerging Trends in Cell Banking (Technical Insights)
Trends in Master and Working Cell Baking
The execution of different test methods aiming to evaluate the stability and potency of biopharmaceutical products, as well as, their pharmacokinetic/pharmacodynamic (PK/PD) profiles, their characterization and comparison with other drugs, or the detection of antidrug antibodies (ADAs) or neutralizing antibodies (NAB), represent critical stages in ...
$3,950.00 -
26 Dec 2014  |  Global  |  Technology Research
Advances in Biosensing Technologies (Technical Insights)
This research service summarises the developments occuring in the biosensing industry.
$3,950.00 -
08 Dec 2014  |  Global  |  Economic and Databases
Healthcare Trends and Game ChangersA Socio-Economic Perspective
Economic Development Innovation: Game Changers in Healthcare
Healthcare delivery and accessibility are critical to the economic development of a country. Using key indicators reflective of the healthcare scenario in a country and comparing them with government expenditure has demonstrated that some countries have improved healthcare conditions despite minimal spending. Innovation in service delivery is key t...
$1,500.00 -
07 Oct 2014  |  Global  |  Market Research
Analysis of the Global Stem Cell Market
The key to Transforming Future of Diagnostic and Therapeutic Medicine
This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market is cover...
$3,950.00 -
03 Oct 2014  |  Global  |  Market Research
Vital Signs - Healthcare News - The Analysts Perspective - September 2014 Issue
This issue of Vital Signs, released on October 3, 2014, discusses Merck KGaAs acquisition of Sigma-Aldrich, highlights from the 2014 AACC Meeting, Abbotts CE Mark for FreeStyle® Libre, laboratory developed test (LDT) regulations, and the sale of Fortis Healthcares Singapore subsidiary, RadLink-Asia Pte Ltd, and its arm, RadLink Singapore.
$450.00 -
04 Aug 2014  |  Global  |  Market Research
2014 New Product Innovation Leadership Award in The Point of Care Diagnostics for the Emergency Medicine Industry
$1,500.00 -
04 Aug 2014  |  Global  |  Market Research
Vital Signs - Healthcare News - The Analysts Perspective - July Issue
This issue of Vital Signs, released on August 5, 2014, discusses the Senators plead to the FDA for the quick action regarding draft guidance on laboratory developed tests (LDTs), Synthetic Biologys Series A funding round, Roches investment in Stratos Genomics, and Indias cap on drug prices.
$500.00 -
11 Jul 2014  |  Global  |  Market Research
Will Virtual CROs and Integrated Business Models Rule the Road
Insights into the innovative steps taken by CROs and pharmaceutical companies in the race for excellence and low-cost trials
This issue of Vital Signs, released on July 11, 2014, discusses game changing strategies in clinical research, including virtual clinical research organization (CRO) and the integrated business model.
$450.00 -
03 Jul 2014  |  Global  |  Market Research
A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS
Antiretroviral Combinations Continue to Transform the Treatment Landscape
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...
$3,950.00 -
01 Jul 2014  |  Global  |  Market Research
Vital Signs - Healthcare News - The Analysts Perspective - June 2014
This issue of Vital Signs, released on July 1, 2014, discusses the FDA approval of Biogens Eloctate, Qiagens acquisition of Primera Dx, Roches acquisition of Genia Technologies, Cues at-home connected lab test, and the Credihealth Teen Clinic.
$450.00